Skip to main content
OpenTrials
Completed

NCT Number: NCT00473785

CVD Risk Reduction Trial

The purpose of this study is to provide lifestyle counselling for protective health behavior (exercise, diet, smoking cessation) to small groups (6-8 subjects) via teleconference. The sample includes individuals at elevated risk for cardiovascular disease (CVD) as well as individuals with established CVD. Our hypothesis is that telephone-based lifestyle counselling will (1) significantly increase protective lifestyle behavior (diet, exercise, smoke-free living) and (2) significantly reduce CVD risk factors at 6-month follow-up.

Completed

Looking for future studies?

Notify Me

Key information

Age range

35 year–74 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Laurentian University / Sudbury and District Health Unit, Greater Sudbury, Ontario, Canada

Loading trial locations.

About this study

COHRT was a 2 parallel-group randomized controlled trial that was designed to assess the efficacy of a community outreach strategy for cardiovascular disease (CVD) risk reduction among individuals at elevated risk for CV events. Randomization was stratified for diagnosis of CHD, type 1 or 2 diabetes, sex, and clinical depression, and blocked within our northern, rural, and urban recruitment sites. A 2X3 mixed factorial design was utilized: 2 Groups (Usual Care, UC/Lifestyle Counselling,LC) X 3 Intervals (Baseline, post-treatment, 6-month follow-up). All subjects received personal CVD risk factor feedback and standardized handouts on heart healthy lifestyle change. The LC group received 6 weekly 1-hour sessions of lifestyle counseling that was provided via teleconference in small groups (4-8 persons). Group facilitators were trained in a manualized protocol of motivational interviewing that was designed for CVD risk reduction through lifestyle change. Weekly supervision was also provided. We hypothesized that the LC group (vs. UC) would significantly increase protective health behavior (exercise, diet, smoke-free living) at post-treatment and 6-month follow-up. The secondary hypothesis was that LC would significantly reduce (1) CVD risk factors, (SBP, DBP, total cholesterol, LDL cholesterol), (2) 10-year absolute risk among subjects without CVD, and (3) significantly increase quality of life as measured by symptoms of depression, psychological stress, and social support.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 35 to 74 years of age,
  • Diagnosis of CVD or Type 1 or 2 diabetes, or
  • ≥2 of the following CVD risk factors:
  • Confirmed diagnosis of hypertension,
  • Dyslipidemia,
  • Males aged ≥55 years/females aged ≥60 years,
  • Family history of CHD or stroke;
  • Current smoker, or
  • BMI ≥ 27.

Exclusion criteria

  • Diagnosis of clinically significant cardiac complications (e.g. arrhythmia, unstable angina) or a congenital cardiac condition;
  • Major psychiatric illness (e.g. psychosis), history of alcohol or drug dependence within the previous year, or residence in a non-private setting.

Treatment and study plan

Group-based motivational interviewing

Behavioral

Individual CVD-risk factor feedback

Behavioral

Education for protective health behavior change

Behavioral

Primary outcomes

  1. Psychometric assessment of change in exercise, diet and smoking

    Time frame: Post-treatment and 6-month follow-up

Secondary outcomes

  1. SBP, DBP, total cholesterol, HDL, LDL, triglycerides and 10-year absolute CVD risk

    Time frame: 6-month follow-up

  2. Psychometric assessment of symptoms of depression, psychological stress, and social support.

    Time frame: post-treatment and 6-month follow-up

Sponsors and collaborators

Lead sponsor

University Health Network, Toronto

Other

Registry information

Official study title

Community Outreach Heart Health and Risk Reduction Trial

Acronym: COHRT

Important dates

Study start
2002
Study completion
2005
First posted
May 15, 2007
Registry last updated
May 15, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.